Literature DB >> 21789698

Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomas.

Jason A Ellis1, Peter Canoll, Paul C McCormick, Neil A Feldstein, Richard C Anderson, Peter D Angevine, Michael G Kaiser, Paul C McCormick, Jeffrey N Bruce, Alfred T Ogden.   

Abstract

Abnormal signaling through the platelet-derived growth factor receptor (PDGFR) has been proposed as a possible mechanism of spinal cord glioma initiation and progression. However, the extent of PDGFR expression in human spinal cord gliomas remains unknown. In this study we perform immunohistochemical analysis of PDGFRα expression in a series of 33 primary intramedullary spinal cord gliomas of different types and grades. PDGFRα was seen to be expressed in a significant subset of these tumors across all major glioma types including ependymoma, oligodendroglioma, pilocytic astrocytoma, astrocytoma, and glioblastoma. These results support the hypothesis that growth factor signaling through the PDGFR may be important for the development of at least a subset of human spinal cord gliomas. Further studies investigating the prognostic significance of PDGFR expression as well as the role of PDGF signaling on the development of intramedullary spinal cord gliomas are warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789698      PMCID: PMC3869991          DOI: 10.1007/s11060-011-0666-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

Review 1.  Radiation therapy and the management of intramedullary spinal cord tumors.

Authors:  S R Isaacson
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Phase II study of sunitinib malate in patients with recurrent high-grade glioma.

Authors:  B Neyns; J Sadones; C Chaskis; M Dujardin; H Everaert; S Lv; J Duerinck; O Tynninen; N Nupponen; A Michotte; J De Greve
Journal:  J Neurooncol       Date:  2010-09-25       Impact factor: 4.130

3.  Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.

Authors:  Jason A Ellis; Michael Castelli; Jeffrey N Bruce; Peter Canoll; Alfred T Ogden
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

4.  Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.

Authors:  John D Hainsworth; Thomas Ervin; Elke Friedman; Victor Priego; Patrick B Murphy; Bobby L Clark; Ruth E Lamar
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

5.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

6.  PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.

Authors:  Tatsuya Ozawa; Cameron W Brennan; Lu Wang; Massimo Squatrito; Takashi Sasayama; Mitsutoshi Nakada; Jason T Huse; Alicia Pedraza; Satoshi Utsuki; Yoshie Yasui; Adesh Tandon; Elena I Fomchenko; Hidehiro Oka; Ross L Levine; Kiyotaka Fujii; Marc Ladanyi; Eric C Holland
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

Review 7.  Adult primary intradural spinal cord tumors: a review.

Authors:  Marc C Chamberlain; Trent L Tredway
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 8.  Chemotherapy for intramedullary spinal cord tumors.

Authors:  C Balmaceda
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

9.  Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.

Authors:  Alan H Shih; Chengkai Dai; Xiaoyi Hu; Marc K Rosenblum; Jason A Koutcher; Eric C Holland
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

Review 10.  Recent insights into PDGF-induced gliomagenesis.

Authors:  Filippo Calzolari; Paolo Malatesta
Journal:  Brain Pathol       Date:  2009-09-25       Impact factor: 6.508

View more
  2 in total

1.  Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.

Authors:  Jessica Amlin-Van Schaick; Sungjin Kim; Karl W Broman; Karlyne M Reilly
Journal:  Mamm Genome       Date:  2011-12-08       Impact factor: 2.957

2.  Unique microenvironmental responses to PDGF stimulation in brain and spinal cord gliomas determine tumor phenotype.

Authors:  Jason A Ellis; Michael Castelli; Marcela Assanah; Jeffrey N Bruce; Peter Canoll; Alfred T Ogden
Journal:  J Neurooncol       Date:  2015-04-14       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.